Investing Profile

Jasper Bos

InvestorVC

General Partner at Forbion

forbion.comAmsterdam, Netherlands

‌

‌

‌

Your Intro Paths to Jasper Bos

‌

‌

‌

‌

‌

‌

‌

‌

‌

‌

‌

‌

Find Jasper Bos on

cb

Current Investing Position

Forbion General Partner

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

10

Jasper Bos is on these Sector & Stage Rankings

Pharmaceuticals (Seed)BioTech (Seed)BioTech (Series A)Pharmaceuticals (Series A)Health IT (Series A)Health & Hospital Services (Series A)Health IT (Seed)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)

Jasper Bos's Investments On Record (7)

Company	StageDateRound Size	Total Raised
Engrail Therapeutics	Series BMar 2024$160M	$220M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Peter Bisgaard (Pivotal bioVenture Partners), Niall O’Donnell (RiverVest), Heath Lukatch (Red Tree Venture Capital)
Precirix	Series BMar 2022$88M	$130M
Co-investors: Simone Botti (INKEF Capital), Marten Steen (HealthCap), Ohad Hammer (Pontifax Venture Capital)
Anaveon	Series BDec 2021$120M	$160M
Co-investors: Florian Müllershausen (Novartis Venture Fund), Ohad Hammer (Pontifax Venture Capital), Denis Patrick (Pfizer Venture Investments)
Inthera Bioscience	Series AJun 2018$5M Series AMay 2017$11M SeedDec 2015$4M	$20M
Co-investors: Mark Krul (Aglaia BioMedical Ventures), Keno Gutierrez (BGV (BioGeneration Ventures)), Nanna Luneborg (Forbion)
Prexton Therapeutics	Series BFeb 2017$31M Series AFeb 2015$10M	$41M
Co-investors: Alan O'Connell (Seroba Life Sciences), Marco Boorsma (Forbion)
ARTSaVIT	Series AJan 2017$6M	$6M
Metabomed	Series AApr 2016$18M	$18M

Investors who invest with Jasper Bos

Antoine Boulanger Piette

Dmitrij Hristodorov

Geert-Jan Mulder